Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$58.48 - $63.48 $58 - $63
1 New
1 $0
Q2 2024

Aug 05, 2024

SELL
$53.58 - $57.02 $267 - $285
-5 Reduced 11.9%
37 $2,000
Q1 2024

May 02, 2024

BUY
$42.56 - $59.82 $1,787 - $2,512
42 New
42 $2,000
Q2 2023

Jul 11, 2023

BUY
$31.86 - $67.26 $637 - $1,345
20 New
20 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.